Sandy Spring Bank Amgen Inc Transaction History

Sandy Spring Bank

  • $2.4 Billion
  • Q3 2024

A detailed history of Sandy Spring Bank transactions in Amgen Inc stock. As of the latest transaction made, Sandy Spring Bank holds 8,169 shares of AMGN stock, worth $2.16 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
8,169
Previous 8,395 2.69%
Holding current value
$2.16 Million
Previous $2.62 Million 0.34%
% of portfolio
0.11%
Previous 0.12%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024
SELL
$309.38 - $337.38 $69,919 - $76,247
-226 Reduced 2.69%
8,169 $2.63 Million
Q2 2024

Aug 06, 2024
SELL
$262.75 - $319.31 $61,220 - $74,399
-233 Reduced 2.7%
8,395 $2.62 Million
Q1 2024

May 08, 2024
SELL
$268.87 - $324.56 $26,080 - $31,482
-97 Reduced 1.11%
8,628 $2.45 Million
Q4 2023

Jan 26, 2024
SELL
$255.7 - $288.46 $202,514 - $228,460
-792 Reduced 8.32%
8,725 $2.51 Million
Q3 2023

Oct 30, 2023
SELL
$218.65 - $271.46 $116,540 - $144,688
-533 Reduced 5.3%
9,517 $2.56 Million
Q2 2023

Aug 04, 2023
SELL
$214.27 - $253.37 $26,569 - $31,417
-124 Reduced 1.22%
10,050 $2.23 Million
Q1 2023

May 05, 2023
SELL
$225.79 - $275.2 $65,704 - $80,083
-291 Reduced 2.78%
10,174 $2.46 Million
Q4 2022

Feb 10, 2023
BUY
$229.03 - $291.01 $148,869 - $189,156
650 Added 6.62%
10,465 $2.75 Million
Q3 2022

Nov 02, 2022
SELL
$224.46 - $253.15 $116,719 - $131,638
-520 Reduced 5.03%
9,815 $2.21 Million
Q2 2022

Jul 21, 2022
SELL
$230.71 - $256.74 $6,690 - $7,445
-29 Reduced 0.28%
10,335 $2.52 Million
Q1 2022

May 03, 2022
SELL
$219.27 - $242.57 $60,299 - $66,706
-275 Reduced 2.58%
10,364 $2.51 Million
Q4 2021

Feb 11, 2022
SELL
$198.88 - $227.6 $55,686 - $63,728
-280 Reduced 2.56%
10,639 $2.39 Million
Q3 2021

Nov 05, 2021
SELL
$212.27 - $248.7 $12,736 - $14,922
-60 Reduced 0.55%
10,919 $2.32 Million
Q2 2021

Aug 09, 2021
BUY
$233.58 - $259.14 $261,376 - $289,977
1,119 Added 11.35%
10,979 $2.68 Million
Q1 2021

May 03, 2021
SELL
$221.91 - $258.6 $13,980 - $16,291
-63 Reduced 0.63%
9,860 $2.45 Million
Q4 2020

Feb 03, 2021
SELL
$216.38 - $257.67 $23,585 - $28,086
-109 Reduced 1.09%
9,923 $2.28 Million
Q3 2020

Nov 09, 2020
SELL
$234.65 - $260.95 $39,655 - $44,100
-169 Reduced 1.66%
10,032 $2.55 Million
Q2 2020

Aug 12, 2020
SELL
$197.81 - $242.74 $54,199 - $66,510
-274 Reduced 2.62%
10,201 $2.41 Million
Q1 2020

May 01, 2020
SELL
$182.24 - $241.7 $69,615 - $92,329
-382 Reduced 3.52%
10,475 $2.12 Million
Q4 2019

Feb 06, 2020
SELL
$189.21 - $243.2 $10,595 - $13,619
-56 Reduced 0.51%
10,857 $2.62 Million
Q3 2019

Nov 01, 2019
SELL
$174.11 - $208.62 $324,366 - $388,659
-1,863 Reduced 14.58%
10,913 $2.11 Million
Q2 2019

Aug 01, 2019
SELL
$166.7 - $195.41 $78,849 - $92,428
-473 Reduced 3.57%
12,776 $2.36 Million
Q1 2019

May 06, 2019
SELL
$180.87 - $203.88 $81,391 - $91,746
-450 Reduced 3.28%
13,249 $2.52 Million
Q4 2018

Feb 08, 2019
SELL
$178.4 - $208.25 $30,506 - $35,610
-171 Reduced 1.23%
13,699 $2.67 Million
Q3 2018

Nov 07, 2018
SELL
$185.29 - $208.89 $283,864 - $320,019
-1,532 Reduced 9.95%
13,870 $2.88 Million
Q2 2018

Aug 03, 2018
BUY
$166.05 - $186.51 $37,361 - $41,964
225 Added 1.48%
15,402 $2.84 Million
Q1 2018

May 04, 2018
BUY
$169.43 - $198.0 $202,468 - $236,610
1,195 Added 8.55%
15,177 $2.59 Million
Q4 2017

Feb 02, 2018
SELL
$168.79 - $188.59 $239,681 - $267,797
-1,420 Reduced 9.22%
13,982 $2.43 Million
Q3 2017

Nov 03, 2017
BUY
$167.29 - $191.0 $64,908 - $74,108
388 Added 2.58%
15,402 $2.87 Million
Q2 2017

Aug 11, 2017
BUY
N/A
15,014
15,014 $2.59 Million

Others Institutions Holding AMGN

# of Institutions
3,125
Shares Held
409M
Call Options Held
7.56M
Put Options Held
7.2M
View Full List

About AMGEN INC

AMGN Quotes by TradingView
  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Sandy Spring Bank Portfolio

Follow Sandy Spring Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sandy Spring Bank, based on Form 13F filings with the SEC.

News

Stay updated on Sandy Spring Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email